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ABSTRACT  The oxidation of very long chain fatty acids and synthesis  of ether glycerolipids (plasmal- 
ogens)  occurs  mainly  in  peroxisomes.  Zellweger's cerebrohepatorenal  syndrome  (CHRS) is a rare, 
inherited metabolic disease characterized by an apparent absence of peroxisomes, an accumulation 
of very long chain fatty acids, and a decrease  of plasmalogens  in tissues and cultured fibroblasts from 
these patients. As peroxisomes are ubiquitous in mammalian cells, we examined  normal and CHRS- 
cultured  fibroblasts  for their presence,  using an electron  microscopic  histochemical  procedure for 
the subcellular  localization  of catalase,  a peroxisomal  marker enzyme. Small (0.08-0.20/zm)  round 
or  slightly  oval  peroxisomes  were  seen  in  both  normal  and  CHRS  fibroblasts.  The  number  of 
peroxisomes was analyzed morphometrically and found to be significantly  reduced in all CHRS cell 
lines.  These  results  are  discussed  in  relation to the  underlying defect  in  peroxisomal  function  and 
biogenesis  in this disease. 
Peroxisomes are  respiratory organelles that  contain  H202- 
generating oxidases and  catalase  (12).  They are  found  in 
plants,  fungi,  protozoa, and  metazoan  organisms,  and  are 
ubiquitous in  mammalian  cells  (11).  Their unique role in 
ether glycerolipid (plasmalogen) biosynthesis (7, 8) and very 
long chain fatty acid oxidation (23)  suggests  that they are 
essential  to  cellular  metabolism.  Further  support  for this 
concept is derived from studies of  inborn errors of  metabolism 
where expression of a hereditary abnormality results in defec- 
tive peroxisomal function and severe multisystem disease (5, 
6). 
Zellweger's cerebrohepatorenal syndrome (CHRS) t  is  an 
inherited metabolic disorder characterized by severe nervous 
system dysfunction, including demyelination and defective 
neuronal migration, hepatic fibrosis,  skeletal abnormalities, 
and renal cortical cysts (I, 24). Affected infants rarely survive 
beyond one year. At the subeellular level,  the most striking 
abnormality is an apparent lack ofperoxisomes in hepatocytes 
(6,  14,  18)  and  renal proximal tubular epithelia (6).  As  a 
disease, CHRS appears to be unique in that the biogenesis of 
a constitutive organelle is defective. Other syndromes such as 
neonatal adrenoleukodystrophy share many of the clinical, 
biochemical, and morphological features of CHRS (1, 4). In 
f Abbreviation  used  in  this paper.  CHRS, cerebrohepatorenal syn- 
drome. 
contrast to CHRS, reduced numbers of small hepatocellular 
peroxisomes have been detected in these patients, who are 
less impaired and survive for as long as six years (4). 
Biochemical evidence in support of  the concept that CHRS 
represents a profound deficiency in peroxisomes comes from 
two sets of observations. In the liver,/~-oxidation of very long 
chain fatty acids (C:22-26) and the initial step in ether gly- 
cerolipid (plasmalogen) synthesis occurs mainly, if not exclu- 
sively, in peroxisomes (7, 8, 23). Very long chain fatty acids 
accumulate in tissues and fibroblasts from CHRS patients (1), 
whereas plasmalogen concentrations and the activity of di- 
hydroxyacetone phosphate acyltransferase, a key enzyme in 
plasmalogen synthesis, are <10% of normal (3, 9). These data 
have been interpreted as evidence for the absence of peroxi- 
somes in cultured fibroblasts and tissues  from patients with 
CHRS. 
The reported absence of peroxisomes in CHRS fibroblasts, 
which nevertheless grow normally in vitro, and in other tissues 
is contrary to evidence for an essential role of this organelle 
in  mammalian  cell  function.  Therefore, we  conducted an 
ultrastructural and morphometric study to determine whether 
peroxisomes are  present in  normal and CHRS  fibroblasts, 
using a histochemical procedure for the subcellular localiza- 
tion of peroxisomal catalase (15). The results show that small 
catalase-positive peroxisomes were present in the cytoplasm 
of normal and CHRS fibroblasts.  Morphometric analysis of 
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Morphometric Analysis  of Peroxisomal Number in CHRS and 
Normal Fibroblasts 
Sample  P  Age 
No. of per- 
oxisomes 
per 103 #m  2  %  Stu- 
cytoplasmic  con-  dent's 
n  area  trol  t test 
mean +- Sf 
Wl-38  8  Fetal  12  10.1  +  1.2  100.0a 
GM4340"  7  6 mo  14  0.7 _  0.4  6.9b 
GM0228"  8  6 mo  10  0.9 _  0.5  8.9b 
LF*  9  5 yr  10  2.5 +  0.2  24.8c 
SC*  9  3 yr  !  14  5.4 +  0.7  53.5d 
Wl-38 fibroblast culture derived from normal fetal lung was kindly supplied 
by Dr. Ora Rosen, Sloan  Kettering Institute, NY. Statistically significant (P < 
0.01) variation between the samples is indicated  by differences  between 
the letters;  use of the same letter represents the absence of statistically 
significant variation.  P, passage number at time of sampling for ultrastruc- 
tural morphometry, n, number of whole cell profiles analyzed. 
CHRS fibroblast  cell cultures  from the Mutant Cell Repository, Camden, 
N  J, derived from primary cultures of skin biopsy samples. 
* CHRS fibroblast  cultures  derived from  primary cultures  of  skin  biopsy 
samples provided by Dr. Ann Moser, Johns Hopkins University School of 
Medicine, Baltimore, MD. 
! Patient still living. 
these cells revealed that in all CHRS fibroblasts the number 
of peroxisomes was markedly diminished. 
MATERIALS  AND  METHODS 
Culture and Fixation Conditions:  Four  CHRS cell lines were 
examined  by electron  microscopy and cytochemistry,  one from each of two 
classical CHRS patients who died at 6 mo and one from each of two clinically 
atypical patients who had features of both CHRS and neonatal  adrenoleuko- 
dystrophy (Table i). One of the latter group died at 5 yr; the other is 3 yr old. 
Fibroblast cell cultures were grown in tissue culture flasks containing Dulbecco's 
modified Eagle's medium with 10% (vol/vol) fetal calf serum at 37"C in a 5% 
CO2  environment.  For ultrastructural  and  cytochemical  studies  cells were 
harvested at near confluence with 0.2% (wt/vol) trypsin-ethylenediaminetetraa- 
cetic  acid, resuspended  in  culture  medium  without  fetal calf  serum,  and 
collected by centfifugation  for  10  min at  1,000 rpm. The  supernatant  was 
removed and the remaining cells were gently resuspended and fixed with either 
formol-calcium  (21) or 2.5-3.0%  glutaraldehyde in 0.1  M sodium cacodylate 
buffer, pH 7.2. The cells were first placed in fixative at room temp for 15 min 
and then fixed on ice for 2-4 h (glutaraldehyde) or  12  h (formol-calcium). 
After fixation, cells were collected by centrifugation and resuspended in 0.1 M 
cacodylate buffer containing  5% sucrose. This step was repeated three or four 
times to remove excess fixative. 
Ultrastructural Cytochemistry and Morphometry:  Fixedcells 
were  incubated  for 90-120  min  at  37"C in  a  histochemical  medium (15) 
adjusted to pH 9.8-10.2  for the in situ demonstration  of peroxisomal catalase 
activity. Control  cells were first treated with 0.01 M 3-1,2,4-aminotriazole for 
30 min and then incubated  in the complete reaction medium plus aminotria- 
zole, or in a  reaction  medium without  3,5-diaminobenzidine  and hydrogen 
peroxide. Incubation  in the reaction  medium was followed by from three to 
five washes in 0.1  M  cacodylate  buffer and  post-fixation  with 2%  osmium 
tetroxide in 0.1  M cacodylate buffer, pH 7.2. The cells were then dehydrated 
with a graded series of ethanol and infiltrated with Epon-Araldite/ethanol  (1:2, 
l : 1, 2:1, and 1:0; Polysciences Inc., Warrington, PA). The final plastic mixture 
was polymerized at room temperature  for l d then at 60"C for 2 d. 
All sections were cut with a diamond knife and ultramicrotome.  Semithick 
(~0.5/~m) sections for light microscopy were stained with 1% (wt/vol) toluidine 
blue O and sodium borate (borax) or collected unstained  and examined  with 
bright  field optics.  Ultrathin  sections, either  unstained  or stained  with  lead 
citrate ( 1-3 min; reference 20) and uranyl acetate (20 min) were examined in 
a Siemens Elmiskop  100 electron microscope (Siemens Corp., Medical/Indus- 
trial Groups, lselin, N  J) operating at 80 kV. Whole cell profiles were photo- 
graphed and the minimum sample size was calculated from the distribution  of 
the mean for the number of peroxisomes in each sample population.  Random 
samples from three petri dishes per culture were then morphometrically  ana- 
lyzed for the number of  peroxisomes per 1,000 ~m  2  cytoplasmic area (excluding 
the  nuclear  area)  based  upon linear  intersection  (13). Perixosomes  within 
autophagic  vacuoles were excluded from such quantitation.  Final image mag- 
nifications of  8,000-10,000 were calibrated with a 54,480 line diffraction grating 
replica (Polysciences Inc.). 
RESULTS  AND  DISCUSSION 
Small (0.08-0.20 #m) round or irregularly oval bodies delim- 
ited by a single membrane and containing the coarsely fibrillar 
matrix typical of anucleoid animal  and plant peroxisomes 
were identified in both normal and CHRS fibroblasts (Fig.  1, 
a-d). These particles were histochemically reactive for cata- 
lase activity, a marker enzyme for peroxisomes (12,  15). We 
confirmed that this reaction was due to catalase by incubating 
fibroblasts in 0.01  M  3-amino-l,2,4-triazole, which inhibits 
this enzymes activity (10). After treatment with aminotriazole, 
reaction product was absent from these organelles.  The per- 
oxisomes in cultured fibroblasts were similar in morphology 
and catalase activity to those found in a human hepatocellular 
carcinoma cell line incubated under identical conditions (Fig. 
1  e) and in numerous other mammalian cell types previously 
described (2,  11). In a few CHRS, but not normal, cells the 
cisternae of rough endoplasmic reticulum were dilated and 
moderately electron dense (Fig.  1  b). Otherwise, CHRS and 
normal fibroblast cells were morphologically comparable. 
The detection of peroxisomes in CHRS fibroblasts,  albeit 
in reduced numbers, was surprising as this organelle has not 
been reported in either liver or kidney from patients with this 
disease  (6,  14,  18). However, the original description of the 
peroxisomal deficiency in CHRS cautioned that it is impos- 
sible to demonstrate unequivocally  the absence of  an organelle 
by morphological criteria (6).  Some published micrographs 
suggest that a few small (0.2 ~m) structures resembling per- 
oxisomes, normally 0.5  ~m,  are present in  hepatocytes of 
CHRS patients (18).  Despite the fact that biochemical and 
fractionation studies failed to demonstrate particulate (per- 
oxisomal) enzymatic activity in CHRS (22, 25), the resolution 
and  sensitivity of ultrastructural cytochemistry for catalase 
activity allowed us to identify this organelle in CHRS fibro- 
blasts.  The number of peroxisomes was  analyzed morpho- 
metrically and  found to be substantially diminished  in  all 
CHRS  lines as  compared with  the  control (Table  I).  The 
reduced quantities of plasmalogens (9) and diminished activ- 
FIGURE  1  Electron micrographs of fibroblasts incubated in a histochemical medium for the demonstration of peroxisomal catalase 
activity by the deposition of electron-dense reaction product. (a) A  normal human cell (Wl-38) containing several peroxisomes 
with variable staining for catalase. (Inset)  Heterogeneous distribution of reaction product within a peroxisome. (b and c) CHRS 
(GM 4340) cells. (b) Two peroxisomes in the cytoplasm and two others found adjacent to or within autophagic vacuoles (arrows). 
(c)  Peroxisome adjacent to vesicular-tubular portion of smooth endoplasmic reticulum. (d) A  CHRS (LF) cell with peroxisomes 
adjacent to or within autophagic vacuoles (arrows). (e) A  peroxisome of a human hepatocellular carcinoma cell (PsTG-2).  Cells in 
a and-inset fixed with formol-calcium; all other material fixed in glutaraldehyde. Bars:  (a, b, and d) 0.5/~m; (inset,  c, and e) 0.2 
#m. (a) x  18,900; (inset)  x  60,000; (b) x  12,500; (c) x  20,000; (d) x  32,500; (e) x  90,000. 
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¢/-oxidation of very long chain fatty acids in cultured fibro- 
blasts and tissues from CHRS patients (l) are consistent with 
the numerical decrease ofperoxisomes reported here. Analysis 
of variance with the Student's t test revealed significant dif- 
ferences (P <  0.01) between the number of peroxisomes in 
normal and CHRS cell lines (Table I). In patients with the 
classical  form  of CHRS  the  number  of peroxisomes  was 
reduced by 91-93%,  whereas in longer-lived and clinically 
atypical CHRS patients this reduction was only 46-75%  of 
the control value. Variations in the number of peroxisomes 
in different CHRS lines may be related to the clinical severity 
of the disease (Table I). However, more extensive studies are 
required  to determine whether this is a consistent and pre- 
dictable  feature.  The  quantity of peroxisomes  in  cultured 
CHRS fibroblasts  may differ from in vivo fibroblast  popula- 
tions; identification and quantitation of peroxisomes in fibro- 
blasts  of skin  biopsy samples  from  CHRS  patients should 
clarify this point and extend our in vitro observations. 
In liver and kidney, peroxisomes are usually degraded by 
autophagocytosis (17,  19).  In  all  cell  lines that we  studied 
peroxisomes were found in vacuoles, some of which contained 
cytoplasmic debris (Fig.  1,  b and d). Autophagy of peroxi- 
somes may reflect a cellular response to altered  peroxisomal 
membrane constituents during organelle maturation and sen- 
secence. A membrane defect has been hypothesized in CHRS 
and related syndromes but evidence for such an anomaly has 
not  been  obtained.  The  only  peroxisomal  enzyme  whose 
activity is known to be deficient in CHRS is dihydroxyacetone 
phosphate  acyltransferase,  which  catalyzes  the  initial  step 
during the synthesis of plasmalogens (3, 7, 8).  This group of 
ether glycerolipids comprises >20% of the lipid in the human 
brain (16) and is widely distributed in cellular membranes. 
Except for platelet activating factor,  their function in animal 
cells is poorly understood. 
Little is known of the factors that regulate the formation of 
peroxisomes.  Peroxisomal  enzymes are  synthesized on free 
polysomes and transported through the cytosol into the target 
organelle (12). In CHRS, the total activity of matrix enzymes, 
e.g., catalase,  D-amino acid oxidase, and L-alpha hydroxy acid 
oxidase is not reduced in liver or cultured fibroblasts  (22, 25). 
In contrast, the activity of a peroxisomal membrane-associ- 
ated enzyme (dihydroxyacetone phosphate acyltransferase)  is 
decreased  to  <10%  of the control  value (3).  Whether this 
enzymatic deficiency is of pathogenetic significance in CHRS 
(3) or is simply a reflection of the quantitative decrease  in 
peroxisomes reported here remains to be determined.  How- 
ever,  the fact  that this activity is not reduced in parents of 
CHRS  patients (3) indicates that the basic defect  lies else- 
where. Further investigations of fibroblasts  from this disorder 
of peroxisomal  biogenesis  should contribute to  our under- 
standing of peroxisomal formation and their role in cellular 
metabolism. 
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